ArticleGenetics in medicine open2025
Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time.
Barbara K Burton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it